Dual targeting of mTOR and p53 shows potent activity against aggressive Acute monocytic leukaemia

○Jingmei Li

Presentation information

Oral Presentation

(E) Pharmaceutical Health Care and Sciences

[30-503-pm] Pharmacotherapies (Cancer) 1

Sat. Mar 30, 2024 3:30 PM - 4:30 PM [Room 503] Conference Center 503 (5F)

Chair: Ryoichi Yano, Hiromasa Tsuyama

3:42 PM - 3:54 PM

[30-503-pm02S] Dual targeting of mTOR and p53 shows potent activity against aggressive Acute monocytic leukaemia

○Jingmei Li¹, Emi Sugimoto¹, Keita Yamamoto¹, Yutong Dai¹, Sung-Joon Park², Kenta Nakai², Toshio Kitamura^3,4, Susumu Goyama¹ (1. Grad. Sch. Frontier. Sci., Tokyo Univ., 2. IMSUT, 3. Grad. Sch. Pharm. Sci., Tokyo Univ., 4. FBRI)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[30-503-pm] Pharmacotherapies (Cancer) 1

[30-503-pm02S] Dual targeting of mTOR and p53 shows potent activity against aggressive Acute monocytic leukaemia

Password